BridgeMD
New treatment option for Oncology
Official title Impact of Adapted Aesthetic Onco in Patients With Upper Aerodigestive Tract Cancer During Their Management
ClinicalTrials.gov ID: NCT06959810
What this study is testing
- What it's testing
- Treatment for cancers of the pharyngolarynx is mutilating, with major consequences for patients' lives in terms of physical and functional after-effects. The psycho-social consequences are also significant, notably the metamorphosis of identity linked to the disease and its treatment, which alters the patient's self-image.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient aged 18 or over
- Neoplastic location: oropharynx, oral cavity, hypopharynx, larynx, nasal cavity, salivary glands, cavum, sinus.
- Patient due to start oncological treatment (recurrence authorized)
- Patient fluent in French.
- Affiliation with a social security scheme
You likely can't join if
- Breast-feeding or pregnant patient
- Any associated medical or psychological condition that could compromise the patient's ability to participate in the study
- Patient deprived of liberty, under guardianship, or subject to a legal protection measure or unable to express their consent.
- Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons.
See the full eligibility criteria
- Patient aged 18 or over
- Neoplastic location: oropharynx, oral cavity, hypopharynx, larynx, nasal cavity, salivary glands, cavum, sinus.
- Patient due to start oncological treatment (recurrence authorized)
- Patient fluent in French.
- Affiliation with a social security scheme
- Signature of informed consent prior to any specific procedure linked to the study
- Treatment with curative intent
- Breast-feeding or pregnant patient
- Any associated medical or psychological condition that could compromise the patient's ability to participate in the study
- Patient deprived of liberty, under guardianship, or subject to a legal protection measure or unable to express their consent.
- Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons.
The study team makes the final eligibility decision.
Where it's taking place
- Caen, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Caen, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.